Lazma is a unique triple combination topical therapy for the short-term (8-week ) treatment for the Skin dark spots facial melasma. Lazma Cream should always be used in conjunction with sun-avoidance measures.
No one is really certain exactly what causes melasma, but there are many factors that can trigger it including pregnancy, birth control pills, hormone therapy, cosmetics, and anti-seizure medications. Because melasma is so common during pregnancy, it is sometimes referred to as “the mask of pregnancy.” Sun exposure is also a major melasma trigger because ultraviolet (UV) light from the sun can increase melanin production.
Lazma is the only FDA-approved melasma treatment with 3 active ingredients, uniquely combined and more effective then treatments containing only two of the ingredients.
Lazma Cream is a unique triple-combination topical therapy for the short-term (8-week ) treatment of the dark spots associated with moderate-to-severe facial melasma.
Hydroquinone 4% is a depigmenting agent that interrupts the formation and synthesis of melanin to help lighten the skin.
Tretinoin 0.05% works by increasing the skin cell turnover rate, which helps exfoliate the skin.
Lazma Cream should always be used in conjunction with sun-avoidance measures, like using sunscreens and wearing protective clothing. Lazma improves the appearance of melasma but continous therapy is required for sustainable results.